Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature

Disease control at 5 years would be a desirable endpoint for elderly multiple myeloma (MM) patients, but biomarkers predicting this are not defined. Therefore, to gain further insights in this endpoint, a population of 498 newly diagnosed transplant-ineligible patients enrolled in two Spanish trials...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Cancer J
Autors principals: Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Nuñez-Córdoba, Jorge M., Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Puig, Noemí, Oriol, Albert, Paiva, Bruno, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6423121/
https://ncbi.nlm.nih.gov/pubmed/30886139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0176-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars